【24h】

Na/Ca Exchange and Cardiac Ventricular Arrhythmias

机译:钠/钙交换和心脏室性心律失常

获取原文
获取原文并翻译 | 示例

摘要

Ventricular arrhythmias are a major cause of death in cardiovascular disease. Ca~(2+) removal from the cell by the electrogenic Na/Ca exchanger is essential for the Ca~(2+) flux balance during excitation-contraction coupling but also contributes to the electrical events. "Classic" views on the exchanger in arrhythmias include its well-recognized role as depolarizing current underlying delayed afterdepolarizations (DADs) during spontaneous Ca~(2+) release and the alterations in expression in certain forms of cardiac hypertrophy and heart failure. "Novel" views relate to more subtle roles for the exchanger in arrhythmias. Na/Ca exchange function in disease could be modulated indirectly, through phosphorylation or anchoring proteins. Ongoing studies relate Na/Ca exchange to variability in action potential duration (APD) and early afterdepolarizations (EADs) in a dog model of cardiac hypertrophy and arrhythmias. Further research on drugs that target Na/Ca exchange will have to carefully examine the effects on Ca~(2+) balance.
机译:室性心律失常是心血管疾病死亡的主要原因。通过电致Na / Ca交换剂从细胞中去除Ca〜(2+)对于激发-收缩耦合过程中的Ca〜(2+)通量平衡是必不可少的,但也有助于电事件。关于心律失常的交换器的“经典”观点包括其公认的作用,即自发Ca〜(2+)释放过程中延迟后去极化(DAD)背后的电流去极化以及某些形式的心脏肥大和心力衰竭的表达改变。 “新颖”的观点与心律失常中换热器的更微妙的作用有关。可通过磷酸化或锚定蛋白间接调节疾病中的Na / Ca交换功能。正在进行的研究将Na / Ca交换与心脏肥大和心律不齐的狗模型中动作电位持续时间(APD)和早期除极后(EAD)的变化相关。针对靶向Na / Ca交换的药物的进一步研究将必须仔细检查对Ca〜(2+)平衡的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号